Abstract:Objective To determine the pharmacokinetics and bioequivalence of 2 gliclazide tablets in Chinese healthy volunteers.Methods A single-center,randomized,cross-over,two way study design was used.Under fasting conditions,a single oral dose of the test or the reference gliclazide tablets was given to 24 subjects (16 males and 8 females).The plasma concentrations of gliclazide were determined by a high performance liquid chromatography-tandem mass spectrometry.The pharmacokinetic parameters were calculated.Results The main pharmacokinetic parameters of gliclzide in the test and the reference preparations were as follows:tmax was (4.50-±-1.89) h and (4.21±-1.61) h;Cmax was (5959.86± 1251.32) ng·mL-1 and (6003.26± 1357.84) ng·mL-1;AUC0-72 was (100 251.84±42 195.63) ng· h · mL-1 and (102 778.12±46 622.56) ng · h · mL-1;AUC0-∞was (105 221.44±48 385.47) ng·h·mL-1 and (108 360.52t53 614.41) ng·h·mL-1;and t1/2 was (13.67±5.51)h and (14.05 ± 6.16) h.The relative bioavailability was (99.01 ± 11.40)％.After logarithmic transformation,the 90％ confidence intervals of Cmax,AUC0-72 and AUC0-∞ were 95.11％-105.02％,86.33％-111.13％ and 86.89％-110.77％,respectively.No significant difference was found among the main pharmacokinetic parameters between the trial preparation and the reference preparation (P ＞ 0.05) by ANOVA.No significant difference was found in tmax between the trial preparation and the reference preparation (P ＞ 0.05) by nonparametric test.The two one-sided t-tests showed that the trial preparation and the reference preparation were bioequivalent.No adverse events were found or reported during the study.Conclusion The 2 gliclazide tablets are bioequivalent.

Bioeguivalent Study of Two Glipizide Capsules in Human Plasma

Optimal Determination of Gliclazide in Human Plasma by HPLC Method with Solide-Phase Extraction

Study on the Relative Bioavailability and Bioequiavailability of Glipizide Capsule

Bioequivalence of glycyrrhizin capsules by HPLC-MS

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers

Bioequivalence of glipizide orally disintegrating tablets in healthy volunteers

HPLC-fluorescence Determination of Glibenclamide in Human Plasma

Bioequivalence Study of Glibenclamide in Xiaotangling Granules

Determination of Gliqudone in Human Plasma by HPLC-fluorescence and Bioequivalence of 2 Gliqudone Tablets

Determination of Glipizide in Plasma by HPLC-MS and Study on Its Pharmacokinetics in Healthy Subjects

Determination of Gliquidone in Human Plasma by LC-MS/MS and Bioequivalence Study of Its Two Tablets

Bioequivalence of gliclazide tablets in Chinese healthy volunteers

Determination of Gliclazide in Human Plasma by Solid- phase Extraction Combined with HPLC

Pharmacokinetics and bioequivalence of nateglinide in healthy volunteers

Bioequivalence of Gliclazide Sustained Release Tablets

Study on bioequivalence and pharmacokinetics of compound glycyrrhizin capsules in healthy volunteers

Bioequivalence of Rosiglitazone in Healthy Volunteers

Study on bioequivalence of domestic and imported glipizide tablets

Study of the Bioequivalence of Gliclazide in Chinese Healthy Volunteers

Determination of Nateglinide in Human Plasma by LC-ESI-MS and Its Application to Bioequivalence Study

Simultaneous quantification of metformin and glipizide in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.